Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation.

Dobrowolska H, Gill KZ, Serban G, Ivan E, Li Q, Qiao P, Suciu-Foca N, Savage D, Alobeid B, Bhagat G, Colovai AI.

Cytometry B Clin Cytom. 2013 Jan-Feb;84(1):21-9. doi: 10.1002/cyto.b.21050. Epub 2012 Oct 18.

2.

CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.

Cascavilla N, Musto P, D'Arena G, Melillo L, Carella AM, Petrilli MP, Sanpaolo G, Carotenuto M.

Haematologica. 1998 May;83(5):392-7.

3.

High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.

Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H.

Am J Hematol. 2005 May;79(1):26-35.

4.

CD117/CD34 expression in leukemic blasts.

Wells SJ, Bray RA, Stempora LL, Farhi DC.

Am J Clin Pathol. 1996 Aug;106(2):192-5.

PMID:
8712172
5.
7.
8.

Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.

Tokura Y, Shikami M, Miwa H, Watarai M, Sugamura K, Wakabayashi M, Satoh A, Imamura A, Mihara H, Katoh Y, Kita K, Nitta M.

Leuk Res. 2002 Jan;26(1):29-36.

PMID:
11734301
9.

Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.

Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.

Eur J Haematol. 2004 Feb;72(2):89-106.

PMID:
14962246
10.

Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.

Schwartz S, Heinecke A, Zimmermann M, Creutzig U, Schoch C, Harbott J, Fonatsch C, Löffler H, Büchner T, Ludwig WD, Thiel E.

Leuk Lymphoma. 1999 Jun;34(1-2):85-94.

PMID:
10350335
12.

Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.

Porwit-MacDonald A, Ivory K, Wilkinson S, Wheatley K, Wong L, Janossy G.

Leukemia. 1995 Jul;9(7):1191-8.

PMID:
7543174
13.

Detailed analysis of FLT3 expression levels in acute myeloid leukemia.

Kuchenbauer F, Kern W, Schoch C, Kohlmann A, Hiddemann W, Haferlach T, Schnittger S.

Haematologica. 2005 Dec;90(12):1617-25.

14.

Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.

Haase D, Feuring-Buske M, Schäfer C, Schoch C, Troff C, Gahn B, Hiddemann W, Wörmann B.

Leukemia. 1997 May;11(5):674-9.

PMID:
9180291
15.

Epithelial membrane antigen (EMA) or MUC1 expression in monocytes and monoblasts.

Leong CF, Raudhawati O, Cheong SK, Sivagengei K, Noor Hamidah H.

Pathology. 2003 Oct;35(5):422-7.

PMID:
14555387
16.

C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.

Auewarakul CU, Lauhakirti D, Promsuwicha O, Munkhetvit C.

Ann Hematol. 2006 Feb;85(2):108-12. Epub 2005 Dec 1.

PMID:
16320053
17.

Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.

Re F, Arpinati M, Testoni N, Ricci P, Terragna C, Preda P, Ruggeri D, Senese B, Chirumbolo G, Martelli V, Urbini B, Baccarani M, Tura S, Rondelli D.

Exp Hematol. 2002 Feb;30(2):126-34.

PMID:
11823047
18.

[In vitro stimulation of specific antileukemia T-cell response by dendritic cells derived from CD14+ acute monocytic leukemia cells].

Sheng LX, Xie XB, Qiu GQ, Gu WY, Wang ZL, Wu HQ.

Ai Zheng. 2005 Nov;24(11):1338-44. Chinese.

PMID:
16552959
19.

[Clinical significance of CD117/CD34 co-expression in adult patients with acute leukemia].

Shi H, Zhu F, Xiao AQ, Zhang ZR, Zhang R.

Ai Zheng. 2006 Jun;25(6):762-4. Chinese.

PMID:
16764777
20.

XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis.

Tamm I, Richter S, Scholz F, Schmelz K, Oltersdorf D, Karawajew L, Schoch C, Haferlach T, Ludwig WD, Wuchter C.

Hematol J. 2004;5(6):489-95.

PMID:
15570290

Supplemental Content

Support Center